Specified Drug-Use Survey on Entyvio for IV Infusion 300 mg
Latest Information Update: 26 Feb 2025
At a glance
- Drugs Vedolizumab (Primary)
- Indications Ulcerative colitis
- Focus Adverse reactions
- Sponsors Takeda
Most Recent Events
- 07 Nov 2024 Status changed from active, no longer recruiting to completed.
- 02 Jun 2023 Status changed from recruiting to active, no longer recruiting.
- 14 May 2023 Planned End Date changed from 31 Oct 2023 to 31 Oct 2024.